China (Nanjing) International Biotech Conference & Exhibition

公司 每日财经网

Biotech China – The Most Popular Biopharma Event Shining Nanjing in September!

Following the success of the last edition, 2015 Biotech China—The All China Biotech Conference & Exhibition will be held on Sept.21-23 in Nanjing International Expo Center. Biotech China, Sponsored by Nanjing Municipal Peoples’ Government Exhibition Office and China Quality Association for Pharmaceuticals, represents the top level of China bio industry. 2015 Biotech China will welcome more world wide famous exhibitors, pay more attention to build trade platform, hold more frontier conferences and forums. The curtains of distinguished Bio Party will be opened.

Major Upgrading of Exhibition Hall

Nanjing International Expo Center Hall covers an area of 168,000 square meters which be composed of eight single pavilions. Totally contain 5760 indoor standard booths and 30,000 square meters outdoor exhibition area. The third phase of Nanjing International Expo Center will be built this year. 100,000 square meters with 5000 parking spaces and a complete coverage of wifi will present after construction, which solves the “difficult parking” and “no network” problem. Meanwhile, organizers distribute the pavilion with different exhibits in different area that will greatly improve the visiting efficiency.

The special “360 degree no dead” exhibition will ensure the smooth of passenger flow and make each brand can get all-round display.

More Well-Known Enterprises from Home and Abroad

When most expo organizers raise booth fee and expand expo scale by every possible means, Biotech China remains booth fee below the industry average, and strictly controls the quality of exhibitors and exhibition space which aim to attract more professional enterprises and visitors.

Overseas exhibitors from United States, Germany, Australia, South Korea, Japan, Taiwan and many other countries/regions will be available in Sept. in Nanjing. You will find the latest scientific research achievements and technologies around the world, please enjoy yourself in communication and idea exchanging in 2015 Biotech China.

Meanwhile, organizers will set ingenuity "Innovation Island", if you have latest products and technologies, please contact us to join the "Innovation Island" with lowest price and best service.

Furthermore, all "Innovation Island" participator will get special media promotion before and after exhibition.

More Frontier Conferences and Forums

Supported by China Quality Association for Pharmaceuticals, Jiangsu Province Biomedical Industry Associations and other institutions more than 20 institutions, organizers will hold a series of forums, salons, matchmaking and other high-quality concurrent events for different themes during the exhibition. Dynamic events will include: I.The 3rd International Academic Conference on Biological medicine and Pharmaceutics, II. The 2nd China Health Service Conference and Internet+ enlarged Healthplex Upgrading Seminar, III. the discussion of the safety and quality of integrity among pharmaceutical companies, as well as pharmaceutical products salon and a number of promotions on-site.

Welcome to Biotech China 2015 to plan for medicine, seek common development in the autumn on September 21-23, 2015!

SpinalCyte在China Focus @ Europe Vienna上进行呈报

CHINA的待客之道:华光华青瓷惊艳亮相青岛上合国宴

2018年第二届中国保险科技创新国际峰会(2nd InsurTech China 2018)将于9月12-14日在上海召开

✽本文资讯仅供参考,并不构成投资或采购等决策建议(BW)。

弗吉尼亚州阿灵顿--(美国商业资讯)-- Venture Global, Inc. (NYSE: VG)与意大利的Eni S.P.A.今日共同宣布,双方已签署一份新的购销协议(SPA)。根据协议,Eni将在20年内每年从Venture Gl…
  • 能源
  • 7小时前
  • 文传商讯
纽约--(美国商业资讯)--与MSCI全球股票指数挂钩的指数型股票交易所交易基金(ETF)资产规模已超过2万亿美元,自2025年初以来的增长率达17%。 这一增长表明,MSCI指数能很好地满足投资者对全球机遇的探索需求。资产增长的推动力来自…
  • 股市
  • 7小时前
  • 文传商讯
徽商:以行践礼,以商弘道
  • 财经
  • 7小时前
  • 每日财经网
1Globe领导的激进董事会为误导股东的判断公然歪曲纽约法院的裁定,并蓄意隐瞒安提瓜法官上周五拒绝了其立即阻止Prime Success行使投票权的企图 香港--(美国商业资讯)-- Prime Success L.P.(连同其关联方,合称…
  • 公司
  • 6月23日
  • 文传商讯
纽约法院驳回尚珹资本/Prime 紧急禁令救济申请 为股息支付代理公司于2025年7月7日发放每股55.00美元特别现金股息扫清法律障碍 北京--(美国商业资讯)--中国领先的生物制药公司科兴控股生物技术有限公司(Sinovac Biote…
  • 公司
  • 6月23日
  • 文传商讯
—FDA批准的首个用于阿尔茨海默病患者评估的血液体外诊断检测方法— —推出精准、便捷的血液诊断检测将有助于开发和提供更有效的阿尔茨海默病干预措施— 宾夕法尼亚州马尔文和东京--(美国商业资讯)-- Fujirebio今日宣布,该公司的Lum…
  • 公司
  • 5月19日
  • 文传商讯